GlassScriptPhysician profile
Charles S Tomaszewski
NPI 1295794642
$355.48
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2021: $58.31.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $144.58 | 2019 | |
| Astellas Pharma US INC | $103.98 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $37.96 | 2019 | |
| Antares Pharma, INC. | $23.79 | 2019 | |
| 180 Medical, INC. | $15.40 | 2019 | |
| Abbvie INC. | $12.08 | 2019 | |
| Coloplast Corp | $11.37 | 2019 | |
| Clarus Therapeutics INC. | $6.32 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Tomaszewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.